Related Experiment Videos
Hepatolithiasis associated with cholangiocarcinoma
S Kubo1, H Kinoshita, K Hirohashi
1Second Department of Surgery, Osaka City University Medical School, Japan.
World Journal of Surgery
|July 1, 1995
Summary
Hepatolithiasis, or liver stones, can increase cholangiocarcinoma risk. Key diagnostic clues include elevated carcinoembryonic antigen (CEA) and specific stone locations, aiding early cancer detection.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Diagnostic Imaging
Background:
- Hepatolithiasis is a known risk factor for cholangiocarcinoma.
- Accurate pre-treatment diagnosis of associated cholangiocarcinoma is challenging.
Purpose of the Study:
- To identify characteristic clinical features and diagnostic methods for hepatolithiasis.
- To differentiate hepatolithiasis with and without cholangiocarcinoma.
Main Methods:
- Retrospective study of 103 patients with hepatolithiasis (group H) and 10 with hepatolithiasis and cholangiocarcinoma (group HC).
- Analysis of clinical symptoms, serum carcinoembryonic antigen (CEA) levels, and portography findings.
- Classification of intrahepatic stone location (type I-L).
Main Results:
- Jaundice was less common in group HC than group H.
- Elevated CEA levels and type I-L stone location were more frequent in group HC.
- Portography revealed absent portal veins and atrophy in cancerous liver portions in group HC, with higher portal obstruction incidence.
Conclusions:
- Consider cholangiocarcinoma in hepatolithiasis patients with high CEA, type I-L stone location, or absent portal veins on portography.
- Liver resection should be considered for potential undiagnosed cholangiocarcinoma in these high-risk cases.